Gene · 80339
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic opportunities for the treatment of NASH with genetically validated targets. | J Hepatol | 2023 | 37207913 | PubTator, text mining | PubMed |
| Peptic ulcer disease in non-alcoholic fatty liver disease hospitalizations: A new challenge on the horizon in the United States. | World J Hepatol | 2023 | 37206652 | PubTator, text mining | PubMed |
| Comparison between metabolic-associated fatty liver disease and nonalcoholic fatty liver disease: From nomenclature to clinical outcomes. | World J Hepatol | 2023 | 37206648 | PubTator, text mining | PubMed |
| Association Between Physical Activity and Prevalence/Mortality of Non-Alcoholic Fatty Liver Disease in Different Socioeconomic Settings. | Int J Public Health | 2023 | 37206096 | PubTator, text mining | PubMed |
| An international multidisciplinary consensus statement on MAFLD and the risk of CVD. | Hepatol Int | 2023 | 37204656 | PubTator, text mining | PubMed |
| The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease. | Front Cardiovasc Med | 2023 | 37200978 | PubTator, text mining | PubMed |
| Correspondence on Letter regarding "Non-alcoholic fatty liver disease: Definition and subtypes". | Clin Mol Hepatol | 2023 | 37196990 | PubTator, text mining | PubMed |
| PNPLA3 GENE POLYMORPHISM AND RED MEAT CONSUMPTION INCREASED FIBROSIS RISK IN NASH BIOPSY-PROVEN PATIENTS UNDER MEDICAL FOLLOW-UP IN A TERTIARY CENTER IN SOUTHWEST BRAZIL. | Arq Gastroenterol | 2023 | 37194786 | PubTator, text mining | PubMed |
| Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy. | Biomedicines | 2023 | 37189787 | PubTator, text mining | PubMed |
| Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus-The Chicken or the Egg Dilemma. | Biomedicines | 2023 | 37189715 | PubTator, text mining | PubMed |
| Comparison of Machine Learning Models and the Fatty Liver Index in Predicting Lean Fatty Liver. | Diagnostics (Basel) | 2023 | 37189508 | PubTator, text mining | PubMed |
| Plasma Cytokeratin-18 Fragment Level Reflects the Metabolic Phenotype in Obesity. | Biomolecules | 2023 | 37189422 | PubTator, text mining | PubMed |
| The ancestral haplotype markers HLA -A3 and B7 do not influence the likelihood of advanced hepatic fibrosis or cirrhosis in HFE hemochromatosis. | Sci Rep | 2023 | 37179448 | PubTator, text mining | PubMed |
| Gene Polymorphisms and Biological Effects of Vitamin D Receptor on Nonalcoholic Fatty Liver Disease Development and Progression. | Int J Mol Sci | 2023 | 37175993 | PubTator, text mining | PubMed |
| The Values and Perspectives of Organoids in the Field of Metabolic Syndrome. | Int J Mol Sci | 2023 | 37175830 | PubTator, text mining | PubMed |
| Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review. | Int J Mol Sci | 2023 | 37175497 | PubTator, text mining | PubMed |
| UDP-glucuronate metabolism controls RIPK1-driven liver damage in nonalcoholic steatohepatitis. | Nat Commun | 2023 | 37169760 | PubTator, text mining | PubMed |
| Recent advances in NAFLD: current areas of contention. | Fac Rev | 2023 | 37153139 | PubTator, text mining | PubMed |
| Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease. | Clin Gastroenterol Hepatol | 2023 | 37149016 | PubTator, text mining | PubMed |
| Human pluripotent-stem-cell-derived organoids for drug discovery and evaluation. | Cell Stem Cell | 2023 | 37146581 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80339/papers?page=39